Genetic manipulation by targeting defined genomic loci allows the generation of precise mutations in the genome in animal models that can recapitulate genetic defects in human diseases caused by inherited or de novo mutations. However, most of the previous gene-targeting manipulations have been restricted to mice, because their embryonic stem cells are available and can be modulated at defi ned genomic loci [1] . The recent discovery and application of sequence-specific endonucleases, namely transcription activator-like effector nucleases (TALENs) and RNA-guided nucleases (CRISPR/Cas9), have revolutionized genome manipulation in numerous model organisms [2, 3] . In this issue, Liu et al. report the use of TALENs to successfully generate targeted mutations of MECP2 in cynomolgus monkeys.
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The MECP2 gene encodes a methyl-DNA-binding protein that represses gene transcription and plays an important role in mammalian development. It appears to be particularly important for mature neurons. MECP2 is located on the long (q) arm of the X-chromosome, and its mutation in humans can lead to Rett syndrome, a severe neurodevelopmental disorder [4, 5] and one of the most common causes of mental retardation in females, with a prevalence of ~1 per 10,000. The MECP2 locus is X-linked, and the disease-causing alleles are dominant.
As a result, MECP2 mutations have been linked to male lethality. This year, two independent findings [6, 7] in China demonstrated that TALENs are able to create mutations in MECP2 in monkeys; one by Liu et al. from the Institute of Neuroscience, Chinese Academy of Sciences [6] .
Like most investigators, Liu et al. injected TALEN
mRNA into the cytoplasm of one-cell embryos and generated 5 offspring, one of which was positive for mutations in MECP2, giving a 20% targeting rate in monkeys. The mutations appear to be mosaic in the tissues. Also, the male monkey with the MECP2 mutations did not survive after birth. This appears to be consistent with the earlier report on TALEN-mediated mutations in the monkey MECP2 gene [7] .
However, there are differences between these two studies. First, the deletion of MECP2 represents a typical TALEN-mediated mutation [6] , whereas in the mutant monkey reported earlier, the majority were point mutations (single nucleotide exchanges) that were also present in nontargeted DNA regions [7] . The earlier report showed a higher targeting rate; all monkeys examined (two miscarried male fetuses and one live female) had multiple point mutations in the MECP2 gene [7] . Such mutation differences could be due to the different approaches used. In the study by Liu et al., TALEN mRNA was injected into fertilized oocytes [7] whereas in the earlier study TALEN plasmids with RAD51, which assists in the repair of DNA double-strand breaks, were injected into the cytoplasm of fertilized oocytes [8] .
Thus, the cytoplasmic injection of TALEN plasmids with RAD51 may yield a much higher mutagenesis rate in the genome. Another difference is that Liu et al. reported that monkeys with TALEN mutations can survive to full term (160 days of gestation) with grossly normal brain development, whereas in the earlier report two male fetuses carrying MECP2 mutations were dead at day 63 of gestation [7] .
Although both studies indicated male lethality, whether and when the loss of MECP2 causes male lethality remain to be investigated, as both studies showed mosaic mutations in aborted monkeys. However, there were also aborted monkeys without the MECP2 mutations, which could result from TALEN mRNA toxicity or in vitro fertilization and embryo transfer manipulations [6] . 
